TWST
Twist Bioscience Corp
$76.17
+2.86%
$4.7B
No data for this timeframe.
Vol
Market Cap$4.7B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (93%)
Inst. Holders50 funds
Inst. Value$2.8B
Inst. Activity19 buys / 5 sells
Insider Activity0B / 42S
Insider Net $-$9.8M
Reddit Sentiment70° Bullish
SEC Reports11
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. DE·CIK 0001581280·Prev Close $74.05
Recent Activity
Jun 9, 2026
short_volume
Short Volume: TWST — 55.1% short (0.4M / 0.8M)
Short: 425,742 | Exempt: 1,580 | TRF Vol: 773,150 | Short Ratio: 55.1% | Off-exchange volume (dark p
Jun 8, 2026
Insider
WERNER ROBERT F. sold 232 shares
Chief Accounting Officer @ $69.84 ($16.2K)
Jun 8, 2026
Insider
WERNER ROBERT F. gifted 500 shares
Chief Accounting Officer
Jun 8, 2026
Insider
Green Paula sold 884 shares
SVP of Human Resources @ $69.84 ($61.7K)
Jun 2, 2026
SEC
Four insiders at Twist Bioscience sold a total of $1.31M in open-market sales over a 7-day window, including the CEO (vi
CLUSTER — Impact 3/10
Jun 1, 2026
SEC
A cluster of insider selling at Twist Bioscience over the past week, led by CEO Emily Leproust who sold ~$3.2M in open-m
CLUSTER — Impact 3/10
May 28, 2026
SEC
A substantial insider selling cluster at Twist Bioscience, concentrated on May 21-26, 2026, with CEO Emily Leproust alon
CLUSTER — Impact 5/10
Inst.
Invesco Ltd. — ADD
2,171,898 shares ($103.2M)
Price Targets
$66.67
-12.5% upside
Sell
Current $76.17
Low $36.00
Median $66.00
High $85.00
9 analysts
$36.00
$85.00
Analyst Ratings
8Strong Buy
6Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 11, 2026 | Piper Sandler | INITIATE | Overweight → Overweight |
| May 5, 2026 | Leerink Partners | UPGRADE | Market Perform → Outperform |
| May 5, 2026 | Barclays | MAINTAIN | Overweight → Overweight |
| May 5, 2026 | Guggenheim | MAINTAIN | Buy → Buy |
| May 5, 2026 | Baird | MAINTAIN | Outperform → Outperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.16 | $-0.16 — $-0.16 | 66% YoY | 1 |
| Next Q | $-0.06 | $-0.06 — $-0.06 | 87% YoY | 1 |
| Current FY | $-0.58 | $-0.58 — $-0.58 | 73% YoY | 1 |
| Next FY | $-0.97 ▲ +52.7% | $-2.05 — $0.11 | -67% YoY | 2 |
Latest Reports
NEUTRAL
CLUSTER
3/10
Four insiders at Twist Bioscience sold a total of $1.31M in open-market sales over a 7-day window, including the CEO (vi
Jun 2, 2026
NEUTRAL
CLUSTER
3/10
A cluster of insider selling at Twist Bioscience over the past week, led by CEO Emily Leproust who sold ~$3.2M in open-m
Jun 1, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| NOMURA ASSET MANAGEMENT CO | — | — |
| Artisan Partners Limited Partnership | $302.6M | ADD |
| ARK Investment Management LLC | $301.4M | — |
| BlackRock, Inc. | $263.9M | — |
| EdgePoint Investment Group Inc. | $255.8M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 8, 2026 | WERNER ROBERT | SELL | $16.2K |
| Jun 8, 2026 | WERNER ROBERT | G | $0.00 |
| Jun 8, 2026 | Green Paula | SELL | $61.7K |
| Jun 8, 2026 | Leproust Emily | SELL | $158.2K |
| Jun 8, 2026 | Cho Dennis | SELL | $28.1K |
Reddit Sentiment
70°
Bullish
Bearish
Neutral
Bullish
50 institutional holders with $2.8B total value (59,767,405 shares) as of 2026-Q1. Top holders: NOMURA, Artisan, ARK. Net buying activity: 19 institutions added/increased vs 5 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | NOMURA ASSET MANAGEMENT CO LTD | — | $0.00 | 0.0% | — |
| 2 | Artisan Partners Limited Partnership | 6,367,777 | $302.6M | 10.7% | ADD +26.7% |
| 3 | ARK Investment Management LLC | 6,342,733 | $301.4M | 10.6% | — |
| 4 | BlackRock, Inc. | 5,554,362 | $263.9M | 9.3% | — |
| 5 | EdgePoint Investment Group Inc. | 5,382,521 | $255.8M | 9.0% | ADD +31.7% |
| 6 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 5,269,718 | $250.4M | 8.8% | ADD +43.7% |
| 7 | STATE STREET CORP | 3,670,682 | $174.4M | 6.1% | — |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2,649,101 | $125.9M | 4.4% | — |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 2,639,044 | $125.4M | 4.4% | — |
| 10 | Invesco Ltd. | 2,171,898 | $103.2M | 3.6% | ADD +68.3% |
| 11 | FMR LLC | 1,889,945 | $89.8M | 3.2% | DOUBLED +2641.6% |
| 12 | GOLDMAN SACHS GROUP INC | 1,705,546 | $81.0M | 2.9% | — |
| 13 | Sumitomo Mitsui Trust Group, Inc. | 1,496,099 | $71.1M | 2.5% | — |
| 14 | FARALLON CAPITAL MANAGEMENT LLC | 1,427,650 | $67.8M | 2.4% | DOUBLED +18562.1% |
| 15 | CITADEL ADVISORS LLC | 1,220,400 | $58.0M | 2.0% | — |
| 16 | BAILLIE GIFFORD & CO | 1,215,151 | $57.7M | 2.0% | ADD +62.8% |
| 17 | DIMENSIONAL FUND ADVISORS LP | 781,618 | $37.1M | 1.3% | — |
| 18 | WELLINGTON MANAGEMENT GROUP LLP | 738,629 | $35.1M | 1.2% | DOUBLED +171.2% |
| 19 | BALYASNY ASSET MANAGEMENT L.P. | 726,288 | $34.5M | 1.2% | ADD +25.4% |
| 20 | Point72 Asset Management, L.P. | 669,732 | $31.8M | 1.1% | NEW |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| Invesco Ltd. | ADD | 1,290,271 | 2,171,898 | +68.3% | $103.2M | 2026-Q1 |
| FMR LLC | DOUBLED | 68,937 | 1,889,945 | +2641.6% | $89.8M | 2026-Q1 |
| FARALLON CAPITAL MANAGEMENT LLC | DOUBLED | 7,650 | 1,427,650 | +18562.1% | $67.8M | 2026-Q1 |
| BALYASNY ASSET MANAGEMENT L.P. | ADD | 579,370 | 726,288 | +25.4% | $34.5M | 2026-Q1 |
| Point72 Asset Management, L.P. | NEW | — | 669,732 | — | $31.8M | 2026-Q1 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | NEW | — | 584,696 | — | $27.8M | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | ADD | 399,354 | 584,261 | +46.3% | $27.8M | 2026-Q1 |
| MORGAN STANLEY | TRIM | 866,356 | 546,845 | -36.9% | $26.0M | 2026-Q1 |
| LOOMIS SAYLES & CO L P | NEW | — | 492,290 | — | $23.4M | 2026-Q1 |
| Allspring Global Investments Holdings, LLC | NEW | — | 455,446 | — | $22.6M | 2026-Q1 |
| SEI INVESTMENTS CO | ADD | 270,099 | 354,420 | +31.2% | $16.8M | 2026-Q1 |
| Holocene Advisors, LP | NEW | — | 344,758 | — | $16.4M | 2026-Q1 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | ADD | 80,552 | 152,687 | +89.6% | $7.3M | 2026-Q1 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | DOUBLED | 65,122 | 131,265 | +101.6% | $6.2M | 2026-Q1 |
| Legal & General Group Plc | TRIM | 171,206 | 128,075 | -25.2% | $6.1M | 2026-Q1 |
| Russell Investments Group, Ltd. | DOUBLED | 22,444 | 66,565 | +196.6% | $3.2M | 2026-Q1 |
| ENVESTNET ASSET MANAGEMENT INC | ADD | 38,649 | 65,556 | +69.6% | $3.1M | 2026-Q1 |
| BLAIR WILLIAM & CO/IL | TRIM | 81,561 | 57,417 | -29.6% | $2.7M | 2026-Q1 |
| Mariner, LLC | DOUBLED | 6,926 | 16,971 | +145.0% | $805.8K | 2026-Q1 |
| Rockefeller Capital Management L.P. | NEAR_EXIT | 161,535 | 11,253 | -93.0% | $534.7K | 2026-Q1 |
| BNP Paribas Asset Management Holding S.A. | ADD | 780 | 1,038 | +33.1% | $49.3K | 2026-Q1 |
| PNC FINANCIAL SERVICES GROUP, INC. | ADD | 505 | 958 | +89.7% | $45.5K | 2026-Q1 |
| Allworth Financial LP | ADD | 279 | 388 | +39.1% | $18.4K | 2026-Q1 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | NEAR_EXIT | 7,884 | 376 | -95.2% | $17.9K | 2026-Q1 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | ADD | 4,142,283 | 5,954,429 | +43.7% | $188.9M | 2025-Q4 |
9 unique insiders with 50 transactions. Net insider value: -$9.8M ($0.00 bought, $9.8M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | WERNER ROBERT F. | Chief Accounting Officer | SELL | 232 | $69.84 | $16.2K |
| Jun 8, 2026 | WERNER ROBERT F. | Chief Accounting Officer | GIFT | 500 | — | — |
| Jun 8, 2026 | Green Paula | SVP of Human Resources | SELL | 884 | $69.84 | $61.7K |
| Jun 8, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 2,265 | $69.84 | $158.2K |
| Jun 8, 2026 | Cho Dennis | See Remarks | SELL | 402 | $69.84 | $28.1K |
| May 29, 2026 | Laponis Adam | Chief Financial Officer | SELL | 4,000 | $70.00 | $280.0K |
| May 29, 2026 | Cho Dennis | See Remarks | SELL | 14,205 | $69.75 | $990.8K |
| May 28, 2026 | Leproust Emily M. | Chief Executive Officer | EXERCISE | 16,470 | $8.82 | $145.3K |
| May 28, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 1,482 | $65.33 | $96.8K |
| May 28, 2026 | Starovasnik Melissa A. | Director | SELL | 2,500 | $68.00 | $170.0K |
| May 27, 2026 | Leproust Emily M. | Chief Executive Officer | EXERCISE | 25,017 | $8.82 | $220.6K |
| May 27, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 23,752 | $65.24 | $1.5M |
| May 26, 2026 | Starovasnik Melissa A. | Director | SELL | 500 | $61.04 | $30.5K |
| May 26, 2026 | Leproust Emily M. | Chief Executive Officer | EXERCISE | 24,282 | $8.82 | $214.2K |
| May 26, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 24,282 | $65.08 | $1.6M |
| May 26, 2026 | WERNER ROBERT F. | Chief Accounting Officer | SELL | 800 | $62.48 | $50.0K |
| May 21, 2026 | Green Paula | SVP of Human Resources | SELL | 1,399 | $53.26 | $74.5K |
| May 21, 2026 | Finn Patrick John | President and COO | SELL | 4,160 | $53.26 | $221.5K |
| May 21, 2026 | Cho Dennis | See Remarks | SELL | 1,642 | $53.26 | $87.4K |
| May 21, 2026 | WERNER ROBERT F. | Chief Accounting Officer | SELL | 688 | $53.26 | $36.6K |
| May 21, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 6,888 | $53.26 | $366.8K |
| May 21, 2026 | Laponis Adam | Chief Financial Officer | SELL | 2,019 | $53.26 | $107.5K |
| May 12, 2026 | JOHANNESSEN JAN | Director | EXERCISE | 12,000 | $14.00 | $168.0K |
| May 12, 2026 | JOHANNESSEN JAN | Director | SELL | 12,000 | $56.12 | $673.4K |
| May 8, 2026 | WERNER ROBERT F. | Chief Accounting Officer | SELL | 4,961 | $56.88 | $282.2K |
| May 4, 2026 | WERNER ROBERT F. | Chief Accounting Officer | SELL | 164 | $57.15 | $9.4K |
| May 4, 2026 | Cho Dennis | See Remarks | SELL | 1,962 | $57.15 | $112.1K |
| May 4, 2026 | Finn Patrick John | President and COO | SELL | 2,844 | $57.15 | $162.5K |
| May 4, 2026 | Green Paula | SVP of Human Resources | SELL | 1,116 | $57.15 | $63.8K |
| May 4, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 5,127 | $57.15 | $293.0K |
| Apr 23, 2026 | Finn Patrick John | President and COO | SELL | 2,321 | $60.76 | $141.0K |
| Apr 22, 2026 | Leproust Emily M. | Chief Executive Officer | EXERCISE | 8,061 | $8.82 | $71.1K |
| Apr 22, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 7,910 | $65.28 | $516.3K |
| Apr 21, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 1,610 | $65.01 | $104.7K |
| Apr 21, 2026 | Leproust Emily M. | Chief Executive Officer | EXERCISE | 1,610 | $8.82 | $14.2K |
| Apr 17, 2026 | Laponis Adam | Chief Financial Officer | SELL | 4,000 | $60.00 | $240.0K |
| Apr 14, 2026 | Laponis Adam | Chief Financial Officer | SELL | 3,000 | $55.00 | $165.0K |
| Apr 9, 2026 | Laponis Adam | Chief Financial Officer | SELL | 2,597 | $49.89 | $129.6K |
| Apr 1, 2026 | Starovasnik Melissa A. | Director | SELL | 1,000 | $51.00 | $51.0K |
| Mar 20, 2026 | Green Paula | SVP of Human Resources | SELL | 297 | $43.79 | $13.0K |
| Mar 20, 2026 | Cho Dennis | See Remarks | SELL | 354 | $43.79 | $15.5K |
| Mar 20, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 1,742 | $43.79 | $76.3K |
| Mar 17, 2026 | CHESS ROBERT | Director | EXERCISE | 10,000 | $11.89 | $118.9K |
| Mar 17, 2026 | CHESS ROBERT | Director | SELL | 10,000 | $47.00 | $470.0K |
| Mar 6, 2026 | WERNER ROBERT F. | Chief Accounting Officer | SELL | 246 | $46.43 | $11.4K |
| Mar 6, 2026 | Cho Dennis | See Remarks | SELL | 425 | $46.43 | $19.7K |
| Mar 6, 2026 | Green Paula | SVP of Human Resources | SELL | 935 | $46.43 | $43.4K |
| Mar 6, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 2,423 | $46.43 | $112.5K |
| Feb 23, 2026 | Laponis Adam | Chief Financial Officer | SELL | 2,085 | $46.71 | $97.4K |
| Feb 23, 2026 | Green Paula | SVP of Human Resources | SELL | 1,465 | $46.71 | $68.4K |
11 SEC filing reports analyzed. Sentiment: 1 bullish, 5 bearish, 0 mixed, 5 neutral. Avg impact: 4.7/10.
NEUTRAL
CLUSTER
3/10
Four insiders at Twist Bioscience sold a total of $1.31M in open-market sales over a 7-day window, i
Jun 2, 2026
NEUTRAL
CLUSTER
3/10
A cluster of insider selling at Twist Bioscience over the past week, led by CEO Emily Leproust who s
Jun 1, 2026
BEARISH
CLUSTER
5/10
A substantial insider selling cluster at Twist Bioscience, concentrated on May 21-26, 2026, with CEO
May 28, 2026
NEUTRAL
CLUSTER
3/10
Six TWST insiders—including the CEO, CFO, and COO—collectively sold 16,796 shares for ~$807K on May
May 26, 2026
BULLISH
8-K
7/10
Twist Bioscience reported fiscal Q2 2026 revenue of $110.7M, a 19% YoY increase and above the prior
May 4, 2026
NEUTRAL
CLUSTER
4/10
Twist Bioscience CEO Emily Leproust and CFO Adam Laponis sold a combined $345K in shares over the pa
Apr 23, 2026
NEUTRAL
CLUSTER
3/10
Three insiders at Twist Bioscience sold shares in a coordinated open-market transaction on March 20,
Mar 24, 2026
BEARISH
CLUSTER
5/10
Three insiders at Twist Bioscience sold shares in a coordinated 7-day window, including CEO Emily Le
Mar 10, 2026
BEARISH
CLUSTER
6/10
Six insiders at Twist Bioscience Corp, including the CEO, COO, CFO, and other executives, sold share
Feb 26, 2026
BEARISH
CLUSTER
7/10
Four corporate insiders at Twist Bioscience Corp, including the CEO, COO, CFO, and another executive
Feb 26, 2026
BEARISH
CLUSTER
6/10
Three insiders at Twist Bioscience Corp sold shares in a coordinated open-market transaction on Febr
Feb 25, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (93% buy). Based on 15 analysts: 8 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$66.67 mean target
-12.5% upside
Sell (1.40)
$36.00 Low
$85.00 High
| Metric | Value |
|---|---|
| Current Price | $76.17 |
| Target Low | $36.00 |
| Target Mean | $66.67 |
| Target Median | $66.00 |
| Target High | $85.00 |
| # Analysts | 9 |
| Recommendation | Sell (1.40) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.16 | $-0.16 | $-0.16 | 65.7% | — | — | $0.1B | 19.3% | 1 |
| Next Q 2026-09-30 |
$-0.06 | $-0.06 | $-0.06 | 86.7% | — | — | $0.1B | 18.8% | 1 |
| Current FY 2026-09-30 |
$-0.58 | $-0.58 | $-0.58 | 72.6% | — | — | $0.4B | 18.6% | 1 |
| Next FY 2027-09-30 |
$-0.97 | $-2.05 | $0.11 | -67.2% | +52.7% | — | $0.5B | 15.8% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.160 | |
| 7d ago | $0.000 | -0.160 |
| 30d ago | $0.000 | -0.160 |
| 60d ago | $-0.490 | +0.330 |
| 90d ago | $-0.490 | +0.330 |
7 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 11, 2026 | Piper Sandler | INITIATE | Overweight | Overweight |
| May 5, 2026 | Leerink Partners | UPGRADE | Market Perform | Outperform |
| May 5, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| May 5, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| May 5, 2026 | Baird | MAINTAIN | Outperform | Outperform |
| Apr 14, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Mar 30, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| Feb 3, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Feb 3, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Jan 26, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| Jan 8, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Dec 15, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 8 | 6 | 1 | 0 | 0 | 93% | |
| May 1, 2026 | 7 | 7 | 2 | 0 | 0 | 88% | |
| Apr 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% | |
| Mar 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% | |
| Feb 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% | |
| Jan 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
70°
Bullish
Bearish
Neutral
Bullish
6 mentions
4 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 24, 2026 | 3 | 64° Warm | 2 | 0 | 3 |
| Apr 24, 2026 | 3 | 64° Warm | 2 | 0 | 3 |
Recent Reddit Threads
TWST bull run coming. INVEST
▲ 1
💬 1
⚡ 0.5
TWST , BIOSCIENCE BULLISH
▲ 1
💬 0
⚡ 0.5
TWST ticker symbol. INVEST
▲ 1
💬 1
⚡ 0.5
Jun 9, 2026
short_volume
Short Volume: TWST — 55.1% short (0.4M / 0.8M)
Short: 425,742 | Exempt: 1,580 | TRF Vol: 773,150 | Short Ratio: 55.1% | Off-exchange volume (dark pool + OTC)
Jun 8, 2026
short_volume
Short Volume: TWST — 62.6% short (0.3M / 0.5M)
Short: 314,776 | Exempt: 183 | TRF Vol: 502,955 | Short Ratio: 62.6% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
short_volume
Short Volume: TWST — 56.8% short (0.6M / 1.0M)
Short: 583,794 | Exempt: 547 | TRF Vol: 1,026,996 | Short Ratio: 56.8% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: TWST — 57.0% short (0.3M / 0.5M)
Short: 299,805 | Exempt: 8,115 | TRF Vol: 525,783 | Short Ratio: 57.0% | Off-exchange volume (dark pool + OTC)
May 29, 2026
short_volume
Short Volume: TWST — 57.7% short (0.4M / 0.7M)
Short: 397,370 | Exempt: 19 | TRF Vol: 689,144 | Short Ratio: 57.7% | Off-exchange volume (dark pool + OTC)
May 26, 2026
short_volume
Short Volume: TWST — 59.1% short (0.4M / 0.6M)
Short: 363,726 | Exempt: 0 | TRF Vol: 615,112 | Short Ratio: 59.1% | Off-exchange volume (dark pool + OTC)
May 21, 2026
short_volume
Short Volume: TWST — 58.4% short (0.4M / 0.7M)
Short: 391,646 | Exempt: 0 | TRF Vol: 670,972 | Short Ratio: 58.4% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: TWST — 55.0% short (0.3M / 0.6M)
Short: 310,384 | Exempt: 7 | TRF Vol: 564,094 | Short Ratio: 55.0% | Off-exchange volume (dark pool + OTC)
May 4, 2026
earnings_calendar
TWST Q2 2026 Earnings Scheduled — 2026-05-04
Apr 21, 2026
short_volume
Short Volume: TWST — 69.8% short (0.5M / 0.8M)
Short: 545,933 | Exempt: 274 | TRF Vol: 782,047 | Short Ratio: 69.8% | Off-exchange volume (dark pool + OTC)
Apr 15, 2026
short_volume
Short Volume: TWST — 55.0% short (0.3M / 0.5M)
Short: 286,670 | Exempt: 129 | TRF Vol: 520,969 | Short Ratio: 55.0% | Off-exchange volume (dark pool + OTC)
Apr 6, 2026
short_interest
FTD: TWST — 19,702 shares ($1.0M) failed to deliver
Settlement: 20260406, Price: $50.21, FTD Value: $989,237.42, TWIST BIOSCIENCE CORP COM (DE)
Mar 23, 2026
short_volume
Short Volume: TWST — 70.1% short (0.4M / 0.5M)
Short: 350,956 | Exempt: 0 | TRF Vol: 500,661 | Short Ratio: 70.1% | Off-exchange volume (dark pool + OTC)
Mar 18, 2026
short_interest
FTD: TWST — 15,212 shares ($0.7M) failed to deliver
Settlement: 20260318, Price: $47.28, FTD Value: $719,223.36, TWIST BIOSCIENCE CORP COM (DE)
Mar 11, 2026
short_interest
FTD: TWST — 11,626 shares ($0.5M) failed to deliver
Settlement: 20260311, Price: $45.40, FTD Value: $527,820.4, TWIST BIOSCIENCE CORP COM (DE)